Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,950.00
Bid: 9,900.00
Ask: 10,000.00
Change: -150.00 (-1.49%)
Spread: 100.00 (1.01%)
Open: 10,050.00
High: 9,980.00
Low: 9,900.00
Prev. Close: 10,050.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

21 Mar 2011 07:00

RNS Number : 2707D
Judges Scientific PLC
21 March 2011
 

JUDGES SCIENTIFIC plc

("Judges Scientific", "Judges" or the "Company")

 

ACQUISITION OF 51% OF DEBEN UK LIMITED

 

Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, announces that it completed on 18 March the acquisition of a 51% indirect interest in Deben UK Limited ("Deben") for a cash consideration of £3.26 million (the "Acquisition").

 

An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Such payment is expected by Judges to be covered by the cash inherited on completion.

 

The Acquisition has been executed through Bordeaux Acquisition Limited ("BAL"), a 51% owned subsidiary of Judges, which was created for the purpose of effecting the acquisition and which acquired the entirety of Deben's share capital.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed through a £2,422,250 loan provided by Lloyds Bank Corporate Markets to BAL. The loan is split into two parts, both guaranteed by Judges, and comprises an acquisition component of £2.06 million and a property element of £362,250, secured against the freehold property from which Deben operates its business.

 

Equity of £1,013,250 was supplied by the BAL shareholders, pro-rata to their respective interests, predominantly in the form of subordinated loans. Gary and Tracey Edwards, the vendors of Deben, have reinvested £497,000 of their sale proceeds to acquire a 49% shareholding in BAL, while Judges invested £516,250 in respect of its 51% interest.

 

Both parties have entered into a Shareholders' Agreement which includes minority protection provisions and stipulates, inter alia, that BAL has the right of first refusal on potential acquisitions available to the Judges group, provided that such acquisitions meet certain criteria, operate in the field of electron microscopy and can be financed independently by BAL.

 

Information on Deben

Deben designs, manufactures and sells devices used to enable or improve the observation of objects under a microscope. The principal product groups are motor control systems, micro-tensile stages, cooling stages, digital imaging for electron microscopes and beam blanking equipment. The products are sold world-wide to OEM customers (microscope manufacturers that incorporate such equipment in their own instruments) or directly to end users such as universities.

 

The business, established in 1987, is based in Woolpit, Suffolk, and has been managed by Gary Edwards since 1996. It is expected that Mr Edwards, 44, will continue as managing director of Deben for the foreseeable future.

 

Deben's unaudited accounts for the year ended 31 October 2010 show sales of £2 million and pre-tax profits of £862,000. Operating profits, adjusted to eliminate non-recurring items and to reflect Judges Scientific's practices, would have amounted to £707,000. The accounts show net tangible assets of £2.25 million including net cash of £1.36 million. The freehold property was valued on BAL's behalf at £517,500. The price paid for Deben reflects this valuation as well as a multiple of adjusted operating profit.

 

The Board believes that this acquisition is an excellent addition to the Group's electron microscopy business and will be immediately earnings enhancing.

 

Alex Hambro, Chairman of Judges, commented:

"We are delighted to be able to expand our electron microscopy business through the acquisition of Deben. This is a profitable and cash generative business and we expect the transaction, which has not involved the issue of new equity, to be immediately earnings enhancing. We welcome Gary and his team into the Judges group for what we anticipate will be a long and fruitful relationship ".

 

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital: Tel: 020 7408 4090

 

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

Websites:

 Judges Scientific:www.judges.uk.com

 

Deben: www.deben.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURSSRAKAOUAR
Date   Source Headline
16th Jan 20207:00 amRNSTrading Statement and Notice of Final Results
13th Jan 20209:37 amRNSDirector/PDMR Shareholding
2nd Jan 20201:42 pmRNSTotal Voting Rights
18th Dec 20198:49 amRNSHolding(s) in Company
6th Dec 20193:01 pmRNSDirector/PDMR Shareholding
6th Dec 20192:40 pmRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSAcquisition of Moorfield Nanotechnology Limited
21st Nov 20197:00 amRNSSpecial dividend
15th Nov 20197:00 amRNSBlocklisting Return
7th Nov 20193:19 pmRNSDirector/PDMR Shareholding
7th Nov 20192:38 pmRNSDirector/PDMR Shareholding
1st Nov 201910:49 amRNSTotal Voting Rights
9th Oct 201910:20 amRNSDirector/PDMR Shareholding
23rd Sep 20193:49 pmRNSHolding(s) in Company
23rd Sep 20198:45 amRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results
16th Sep 20191:39 pmRNSHolding(s) in Company
9th Sep 201911:26 amRNSDirector/PDMR Shareholding
27th Aug 20191:18 pmRNSHolding(s) in Company
7th Aug 201910:39 amRNSDirector/PDMR Shareholding
2nd Aug 20194:01 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSAppointment of Liberum as Joint Broker
22nd Jul 20197:00 amRNSTrading Update and Notice of Interim Results
17th Jul 201911:43 amRNSHolding(s) in Company
17th Jul 201911:41 amRNSHolding(s) in Company
12th Jul 20199:23 amRNSDirector/PDMR Shareholding
9th Jul 20195:17 pmRNSDirector/PDMR Shareholding
28th Jun 20194:27 pmRNSHolding(s) in Company
7th Jun 20199:14 amRNSDirector/PDMR Shareholding
5th Jun 201912:05 pmRNSBlock listing Interim Review
3rd Jun 201911:57 amRNSTotal Voting Rights
22nd May 20191:39 pmRNSResult of AGM
16th May 20195:37 pmRNSDirector/PDMR Shareholding
9th May 20194:14 pmRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSTotal Voting Rights
29th Apr 20194:21 pmRNSNotice of AGM
9th Apr 20197:00 amRNSHolding(s) in Company
8th Apr 20195:53 pmRNSDirector/PDMR Shareholding
5th Apr 20199:30 amRNSDirector/PDMR Shareholding
1st Apr 20195:59 pmRNSHolding(s) in Company
1st Apr 201912:35 pmRNSTotal Voting Rights
22nd Mar 201911:54 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
7th Mar 20192:22 pmRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
7th Feb 20192:34 pmRNSDirector/PDMR Shareholding
5th Feb 20197:00 amRNSHolding(s) in Company
17th Jan 20197:00 amRNSTrading Statement and Notice of Final Results
9th Jan 20197:00 amRNSDirector/PDMR Shareholding
21st Dec 20183:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.